KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cognex (CGNX) Research & Development (2016 - 2025)

Cognex's Research & Development history spans 17 years, with the latest figure at $36.1 million for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development rose 10.82% year-over-year to $36.1 million, compared with a TTM value of $139.0 million through Dec 2025, down 0.6%, and an annual FY2025 reading of $139.0 million, down 0.6% over the prior year.
  • Research & Development for Q4 2025 was $36.1 million at Cognex, up from $35.1 million in the prior quarter.
  • The five-year high for Research & Development was $38.5 million in Q2 2023, with the low at $31.3 million in Q3 2021.
  • Average Research & Development over 5 years is $34.7 million, with a median of $34.7 million recorded in 2023.
  • Year-over-year, Research & Development rose 14.01% in 2021 and then dropped 6.57% in 2023.
  • Tracing CGNX's Research & Development over 5 years: stood at $35.5 million in 2021, then grew by 4.64% to $37.1 million in 2022, then decreased by 6.57% to $34.7 million in 2023, then fell by 6.21% to $32.5 million in 2024, then rose by 10.82% to $36.1 million in 2025.
  • Per Business Quant, the three most recent readings for CGNX's Research & Development are $36.1 million (Q4 2025), $35.1 million (Q3 2025), and $33.1 million (Q2 2025).